NASDAQ:ASND
Ascendis Pharma A/S Stock News
$121.12
-1.68 (-1.37%)
At Close: May 17, 2024
Ascendis Pharma A/S (ASND) Q4 2019 Earnings Call Transcript
05:30am, Thursday, 02'nd Apr 2020
ASND earnings call for the period ending December 31, 2019.
Gilde Healthcare Raises €416M Venture And Growth Capital Fund
09:38pm, Wednesday, 01'st Apr 2020
Utrecht (the Netherlands), Cambridge, Massachusetts (USA) – based Gilde Healthcare closed Gilde Healthcare V, a €416m ($450m) venture and growth capital fund
Ascendis Pharma A/S Reports Full-Year 2019 Financial Results
08:01pm, Wednesday, 01'st Apr 2020
– On track with 2020 corporate milestones – – Top-line data from PaTH Forward phase 2 trial on track for mid-April – – Conference call today at 4:30 p.m. Eastern.
Ascendis Pharma A/S Reports Full-Year 2019 Financial Results
08:01pm, Wednesday, 01'st Apr 2020
– On track with 2020 corporate milestones – – Top-line data from PaTH Forward phase 2 trial on track for mid-April – – Conference call today...
Afternoon Market Stats in 5 Minutes
04:51pm, Wednesday, 01'st Apr 2020
Movers Indices • S&P 500 ETF (NYSE:SPY) fell 3.16% to $249.22.• Nasdaq ETF (NASDAQ:QQQ) decreased 2.27% to $186.07.• Dow Jones Industrial Average ETF (NYSE:DIA) fell 2.92% to $212.74.• FTSE/Xi
Morning Market Stats in 5 Minutes
02:46pm, Wednesday, 01'st Apr 2020
Movers Indices • S&P 500 ETF (NYSE:SPY) decreased 3.65% to $247.96.• Nasdaq ETF (NASDAQ:QQQ) fell 2.93% to $184.83.• Dow Jones Industrial Average ETF (NYSE:DIA) fell 3.99% to $210.41.• FTSE/Xi
The Daily Biotech Pulse: InflaRx Begins Human Testing For COVID-induced Pneumonia, Chembio, Becton Dickinson Launch Coronavirus Tests
11:38am, Wednesday, 01'st Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 31) * Athersys Inc (NASDAQ: ATHX) * Forty Seven Inc (NA
Ascendis Pharma A/S (NASDAQ:ASND) Stock Rating Upgraded by Zacks Investment Research
09:42am, Wednesday, 01'st Apr 2020
Ascendis Pharma A/S (NASDAQ:ASND) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued on Monday, Zacks.com reports. The firm presently
Earnings Scheduled For April 1, 2020
08:39am, Wednesday, 01'st Apr 2020
Companies Reporting Before The Bell
UniFirst Corporation (NYSE: UNF) is estimated to report quarterly earnings at $1.65 per share on revenue of $457.48 million.
Lamb Weston...
Ascendis Pharma options imply 12.5% move in share price post-earnings ASND
08:19am, Wednesday, 01'st Apr 2020
Ascendis Pharma options imply 12.5% move in share price post-earnings ASND
Sofinnova Investments Strengthens Executive Team with Promotions of Maha Katabi, PhD, CFA and Sarah Bhagat, PhD
01:00pm, Tuesday, 31'st Mar 2020
Sofinnova Investments announces the promotions of Maha Katabi and Sarah Bhagat.
Ascendis Pharma price target raised to $166 from $144 at Canaccord ASND
11:46am, Tuesday, 31'st Mar 2020
Ascendis Pharma price target raised to $166 from $144 at Canaccord Canaccord ASND
Ascendis Pharma (ASND) Gets a Buy Rating from Canaccord Genuity
10:09am, Tuesday, 31'st Mar 2020
In a report released today, Michelle Gilson from Canaccord Genuity maintained a Buy rating on Ascendis Pharma (ASND), with a price target of $166.00. The
Ascendis Pharma (ASND) Gets a Buy Rating from Canaccord Genuity
10:09am, Tuesday, 31'st Mar 2020
In a report released today, Michelle Gilson from Canaccord Genuity maintained a Buy rating on Ascendis Pharma (ASND – Research
Ascendis Pharma A/S (ASND) Scheduled to Post Earnings on Wednesday
05:54am, Tuesday, 31'st Mar 2020
Ascendis Pharma A/S (NASDAQ:ASND) is scheduled to release its earnings data after the market closes on Wednesday, April 1st. Analysts expect Ascendis Pharma A/S to post earnings of ($1.27) per share f
